Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 4 1

Status

Recruiting 4Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 7

Study Type

Observational 9Interventional 7

Sponsor

Cancer Type

Breast 2Lymphoid 1

Conditions

Breast Neoplasms 987Neoplasms 796Carcinoma, Non-Small-Cell Lung 763Prostatic Neoplasms 588Colorectal Neoplasms 484Lung Neoplasms 468Neoplasm Metastasis 413Multiple Myeloma 382Leukemia, Myeloid, Acute 377Ovarian Neoplasms 316Pancreatic Neoplasms 297Melanoma 278Squamous Cell Carcinoma of Head and Neck 258Recurrence 244Carcinoma, Hepatocellular 240Brain Neoplasms 226Glioblastoma 217Triple Negative Breast Neoplasms 204Carcinoma, Renal Cell 200Head and Neck Neoplasms 198Lymphoma 193Stomach Neoplasms 190Precursor Cell Lymphoblastic Leukemia-Lymphoma 189Sarcoma 172Glioma 171Uterine Cervical Neoplasms 169Lymphoma, Non-Hodgkin 169Endometrial Neoplasms 169Lymphoma, Large B-Cell, Diffuse 166Urinary Bladder Neoplasms 160

Interventions

empagliflozin 1Environmental Biomarkers 1Echocardiography 1Carvedilol 1Blood Pressure Determination 1(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Interventional × Cardiotoxicity × 90 days × Clear all
NCT06023576 2026-05-14

A Study of Blood Pressure Control During Cancer Treatment

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
130 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT06844669 2026-05-13

HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy

Washington University School of Medicine

Phase 2 Terminated
7 enrolled
Breast

Breast Neoplasms, Heart Failure, Cardiotoxicity

NCT07572175 2026-05-07

SPARTACUS

Icahn School of Medicine at Mount Sinai

Phase 2 Not yet recruiting
60 enrolled
Lymphoid

Lymphoma, Ventricular Dysfunction, Left, Cardiotoxicity

NCT07528586 2026-04-14

CMR-Onko

Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)

Phase NA Recruiting
93 enrolled

Cardiotoxicity

NCT06183437 2026-03-30

STOP-MED CTRCD

University Health Network, Toronto

Phase 4 Recruiting
335 enrolled

Heart Failure, Neoplasms, Cardiotoxicity

NCT06778122 2026-03-27

BREATHS

University College, London

Phase NA Recruiting
10 enrolled

Inflammation, Cardiotoxicity

NCT07442578 2026-03-18

PULSE

Dana-Farber Cancer Institute

Phase NA Active not recruiting
20 enrolled

Cardiovascular Diseases, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡